Literature DB >> 8382721

Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection.

U Kumar1, J Brown, J Monjardino, H C Thomas.   

Abstract

Sequence variation in the putative large surface glycoprotein (E2/NS1) of hepatitis C virus (HCV) was analyzed over 18 months in 4 patients with chronic relapsing non-A, non-B liver disease, of whom 2 were treated with lymphoblastoid interferon-alpha. Sequence analysis showed marked heterogeneity between isolates from different patients at the hypervariable region mapping to the amino-terminus of E2/NS1 (amino acid position, 386-411) and the extended sequence analyzed again confirmed the existence of two types, HCV1 and HCV2. Sequential nucleotide analysis of the hypervariable region over 1 year for each patient showed 0-9 amino acid changes, more common in the untreated than in the interferon-alpha-treated patients (3 and 9 vs. 1 and 0). Peaks of raised serum transaminases in individual patients showed no consistent association with mutations within this region. However, results do not exclude the possibility that viral persistence may be due to the emergence of "escape mutants" in the hypervariable region.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382721     DOI: 10.1093/infdis/167.3.726

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome.

Authors:  Catherine Gaudy; Alain Moreau; Pascal Veillon; Stephanie Temoin; Francoise Lunel; Alain Goudeau
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 2.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Selection of hepatitis C virus quasispecies during interferon treatment.

Authors:  I Sakuma; N Enomoto; M Kurosaki; F Marumo; C Sato
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  The management of chronic hepatitis C virus infection.

Authors:  J C Booth; J L Brown; H C Thomas
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

5.  Wide range of quasispecies diversity during primary hepatitis C virus infection.

Authors:  Belinda L Herring; Rose Tsui; Lorraine Peddada; Michael Busch; Eric L Delwart
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.

Authors:  Cheryl L Day; Georg M Lauer; Gregory K Robbins; Barbara McGovern; Alysse G Wurcel; Rajesh T Gandhi; Raymond T Chung; Bruce D Walker
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein.

Authors:  P Farci; A Shimoda; D Wong; T Cabezon; D De Gioannis; A Strazzera; Y Shimizu; M Shapiro; H J Alter; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

8.  Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients.

Authors:  S Navas; J Martín; J A Quiroga; I Castillo; V Carreño
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

Authors:  Marian E Major; Kathleen Mihalik; Montserrat Puig; Barbara Rehermann; Michelina Nascimbeni; Charles M Rice; Stephen M Feinstone
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 10.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.